免疫療法治療薬の世界市場予測(~2021):薬種類別(成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ)、治療分野別、需要先別、地域別...市場調査レポートについてご紹介

【英文タイトル】Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific) - Global Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency ‘
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 30)
4.1 Global Immunotherapy Drugs Market Overview
4.2 Market: By Therapy Area & Region
4.3 Market: Geographic Snapshot
4.4 Market, By Type of Drug
4.5 Life Cycle Analysis, By Region (2016)

5 Market Overview (Page No. – 33)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Increasing Adoption of Targeted Therapy Over Traditional Therapy
5.1.1.2 Emergence of Biosimilars
5.1.1.3 Increasing Demand for Mabs
5.1.1.4 High Prevalence Rate of Lifestyle Diseases
5.1.1.5 Fast Track and Orphan Drug Designations
5.1.2 Restraints
5.1.2.1 High Cost of Immunotherapy Treatment
5.1.2.2 High Attrition Rate in the Product Development Cycle
5.1.3 Opportunities
5.1.3.1 Emerging Markets
5.1.3.2 Immunotherapy to Replace Chemotherapy in Cancer Treatment
5.1.4 Challenge
5.1.4.1 Impending Patent Expiry of Top-Selling Biologics

6 Industry Insights (Page No. – 39)
6.1 Introduction
6.2 Epidemiology Coverage
6.2.1 Cancer Epidemiology
6.2.2 Autoimmune Disease Epidemiology
6.3 Pricing and Reimbursement Scenario
6.3.1 U.S.
6.3.2 U.K.
6.3.3 France
6.3.4 Germany
6.3.5 Other European Countries
6.3.6 Japan
6.4 Research Funding & Government Initiatives
6.5 Pipeline Drugs
6.5.1 Phase 1
6.5.2 Phase I/II
6.5.3 Phase II
6.5.4 Phase II/III
6.5.5 Phase III
6.5.6 Application Submitted
6.5.7 Promising Molecules
6.6 Industry Trends
6.7 Key Products Expected to Be Launched
6.8 Treatment Protocols and Line of Therapies
6.8.1 First-Line Therapy
6.8.2 Second-Line Therapy
6.8.3 Other Treatments
6.9 Burning Issues

7 Immunotherapy Drugs Market, By Type of Drug (Page No. – 67)
7.1 Introduction
7.2 Monoclonal Antibodies
7.3 Adult Vaccines
7.3.1 Preventive Vaccines
7.3.2 Therapeutic Vaccines
7.4 Checkpoint Inhibitors
7.5 Interferons Alpha & Beta
7.6 Interleukins
7.7 Other Drugs

8 Immunotherapy Drugs Market, By Therapy Area (Page No. – 79)
8.1 Introduction
8.2 Cancer
8.3 Autoimmune and Inflammatory Diseases
8.4 Infectious Diseases
8.5 Other Therapy Areas

9 Immunotherapy Drugs Market, By End User (Page No. – 88)
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Other End Users

10 Immunotherapy Drugs Market, By Region (Page No. – 93)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 116)
11.1 Introduction
11.2 Strategic Analysis
11.3 Market Share Analysis
11.4 Competitive Situation and Trends
11.4.1 Regulatory Approvals
11.4.2 Collaborations
11.4.3 Agreements
11.4.4 Acquisitions
11.4.5 Expansions

12 Company Profiles (Page No. – 124)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 F. Hoffmann-La Roche AG
12.3 Merck & Co., Inc.
12.4 Novartis International AG
12.5 Johnson & Johnson (A Parent Company of Janssen Biotech, Inc.)
12.6 Glaxosmithkline PLC
12.7 Amgen Inc.
12.8 Abbvie
12.9 Astrazeneca
12.10 Bristol-Myers Squibb
12.11 ELI Lilly and Company

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 157)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details


【レポート販売概要】

■ タイトル:免疫療法治療薬の世界市場予測(~2021):薬種類別(成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ)、治療分野別、需要先別、地域別
■ 英文:Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific) - Global Forecast to 2021
■ 発行日:2017年1月6日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-PH-3926
■ 調査対象地域:グローバル
  • Berry Petroleum Company:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Berry Petroleum Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Berry Petroleum Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
  • 世界のバンカシュランス市場調査:Global Bancassurance Market 2014-2018
    TechNavio's analysts forecast the Global Bancassurance market to grow at a CAGR of 5.98 percent over the period 2013-2018. One of the key factors contributing to this market growth is the enhanced product portfolio for banks and the resulting increase in profitability. The Global Bancassurance market has also been witnessing the increasing participation of foreign private insurance players in banc …
  • Factor Assay:医療検査市場2014
    The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offeri …
  • バイオ農薬の世界市場:バイオ除草剤、バイオ殺虫剤、バイオ殺菌剤、バイオ殺線虫剤
    About Bio-pesticides Bio-pesticides are developed using pathogenic microorganisms, and are used to target a specific pest, which offers an eco-friendly and effective pest control solution. The mostly utilized biopesticides are living organisms that are pathogenic in nature and can destroy the target pest. The following benefits offered by bio-pesticides make them preferable than conventional synth …
  • 2,3-ジメチル-4-ニトロピリジンN-オキシドの世界市場
    2,3-Dimethyl-4-nitropyridine-N-oxide (CAS 37699-43-7) Market Research Report 2014 presents comprehensive data on 2,3-dimethyl-4-nitropyridine-n-oxide markets globally and regionally (Europe, Asia, North America etc.) The report includes 2,3-dimethyl-4-nitropyridine-n-oxide description, covers its application areas and related patterns. It overviews 2,3-dimethyl-4-nitropyridine-n-oxide market, name …
  • Oil India Limited:石油・ガスの開発・生産動向及びコスト分析– 2012
    Oil India Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Oil India Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
  • 世界のフレグランス市場のM&A動向(2014年7月)
    Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global fragrances market during July 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global fragrances market throughout the month. Additionally, the report provides an overview of all the partn …
  • Mixed Dyslipidemia(脂質異常症):グローバル臨床試験動向(2014年上半期)
    Mixed Dyslipidemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mixed Dyslipidemia Global Clinical Trials Review, H1, 2014" provides data on the Mixed Dyslipidemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mixed Dyslipidemia. It includes an overview of the trial numbers and their recruitme …
  • 世界のシリコンエッチングシステム市場:Global Silicon Etching Systems Market 2014-2018
    TechNavio's analysts forecast the Global Silicon Etching Systems market to grow at a CAGR of 3.59 percent over the period 2013-2018. One of the key factors contributing to this market growth is the rising demand for smartphones and tablets. The Global Silicon Etching Systems market has also been witnessing the emergence of product miniaturization. However, the cyclical nature of the Semiconductor …
  • 膵癌治療市場機会分析及び予測(~2017)
    OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in oncology. This report focuses on the current treatment landscape, unmet needs, pipeline and commercial opportunity in the pancreatic cancer market with coverage of both the e …
  • WiFiインフラ市場分析(The Definitive Analysis of WiFi Infrastructure and Market Update)
    Wireless broadband services are critical to the next wave of development in information technology. Wire-less networks and provide mobility and ease of installation, a factor which is significant in the rapid uptake of mobile telephone technology across the developing world where fixed network infrastructure would be prohibitively expensive to install. How will WiFi hold up against WiMAX? What ven …
  • 世界の第3のプラットフォーム(Third Platform)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Third Platform market to grow at a CAGR of 12.04 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for cloud services. The market has also been witnessing the introduction of phablets. However, the issues relating to security of cloud services could pose a challenge to the growth of this ma …
  • 航空救急サービスの世界市場2015-2019
    About Air Ambulance Air ambulance services are sophisticated and advanced medical services provided in a mobile environment. These services have become an essential component of the modern healthcare system. The medical critical care transport saves lives as it is an effective way to shift or carry critical patients to healthcare facilities. The air ambulance transport services are used in war-tor …
  • 世界のバイタルサイン(生命徴候)モニタリング(医療機器)市場
    The global vital signs monitoring devices market includes emergency support and care services and devices, which can be used not only at clinics, but also at a patient’s home. The most significant healthcare trend witnessed recently is the shift of treatment from hospitals to home in order to gain a cost advantage and reduce hospital expenditure. The move from treatment to proactive monitoring is …
  • 世界の鉱山機械サプライヤーベンチマーク2015
    Overall trends in the data revealed: • Revenues for Mining Equipment suppliers have fallen sharply since their 2012 peak. • Aftermarket shares of revenues increased substantially between 2012 and 2014. • Caterpillar is widely recognized as the leading equipment supplier. • Account managers, quality maintenance and services, and on-time delivery have significant impacts on supplier selection. • Mor …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。